| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0112425217758228 | 0.23704883 |
| NSC 733906 | Null | 0.0112425217758228 | -0.22550741 |
| NSC 736164 | pyrazoline derivative | 0.0112425217758228 | 0.42100524 |
| NSC 737613 | Null | 0.0112425217758228 | 0.35724385 |
| NSC 756304 | GW678313X | 0.0112425217758228 | -0.36867056 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0112425217758228 | 0.36152011 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0112425217758229 | 0.60414244 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0112425217758229 | 0.28306826 |
| NSC 637921 | 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- | 0.0114553853234974 | -0.36977083 |
| NSC 638241 | Null | 0.0114553853234974 | 0.43904263 |